Risk factors and clinical impact of postoperative symptomatic venous thromboembolism

Journal of Vascular Surgery

Volumn 45, Issue 2, 2007, Pages

  Gangireddy, Chethan ^a   Rectenwald, John R ^a   Upchurch, Gilbert R ^a   Wakefield, Thomas W ^a   Khuri, Shukri ^b   Henderson, William G ^c   Henke, Peter K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; CAROTID ENDARTERECTOMY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMA; COMORBIDITY; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISSEMINATED CANCER; FEMALE; GENDER; HEART INFARCTION; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; TOTAL HIP PROSTHESIS; URINARY TRACT INFECTION; VENOUS THROMBOEMBOLISM; WEIGHT REDUCTION;

EID: 33846407948     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.10.034     Document Type: Article

References (31)

1. Heit J.A. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 3 (2005) 1611-1617
2. Henke P.K., Schmaier A., and Wakefield T.W. Vascular thrombosis due to hypercoagulable states. Chapter 34. 6th ed (2005), Elsevier Saunders, Philadelphia, PA
3. White R.H., Gettner S., Newman J.M., Trauner K.B., and Romano P.S. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 343 (2000) 1758-1764
4. Wells P.S., Anderson D.R., Bormanis J., Guy F., Mitchell M., Gray L., et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 350 (1997) 1795-1798
5. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 338S-400S
6. Tooher R., Middleton P., Pham C., Fitridge R., Rowe S., Babidge W., et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 241 (2005) 397-415
7. Agnelli G., Bolis G., Capussotti L., Scarpa R.M., Tonelli F., Bonizzoni E., et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the RISTOS Project. Ann Surg 243 (2006) 89-95
8. Daley J., Khuri S.F., Henderson W., Hur K., Gibbs J.O., Barbour G., et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 185 (1997) 328-340
9. Khuri S.F., Daley J., Henderson W., Barbour G., Lowry P., Irvin G., et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 180 (1995) 519-531
10. Khuri S.F., Henderson W.G., DePalma R.G., Mosca C., Healey N.A., and Kumbhani D.J. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 242 (2005) 326-341 discussion 341-3
11. Leizorovicz A., Cohen A.T., Turpie A.G., Olsson C.G., Vaitkus P.T., and Goldhaber S.Z. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110 (2004) 874-879
12. Agnelli G., Bergqvist D., Cohen A.T., Gallus A.S., and Gent M. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 92 (2005) 1212-1220
13. Bergqvist D., Agnelli G., Cohen A.T., Eldor A., Nilsson P.E., Le Moigne-Amrani A., et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346 (2002) 975-980
14. Kucher N., Koo S., Quiroz R., Cooper J.M., Paterno M.D., Soukonnikov B., et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352 (2005) 969-977
15. Axelrod D.A., Stanley J.C., Upchurch Jr. G.R., Khuri S., Daley J., Henderson W., et al. Risk for stroke after elective noncarotid vascular surgery. J Vasc Surg 39 (2004) 67-72
16. Gibbs J., Cull W., Henderson W., Daley J., Hur K., and Khuri S.F. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 134 (1999) 36-42
17. Bernstein C.N., Blanchard J.F., Houston D.S., and Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 85 (2001) 430-434
18. Rectenwald J.E., Myers D.D., Hawley A.E., Linn M.J., Gangireddy C.R., Henke P.K., et al. D-dimer, p-selectin, and microparticles: novel markers to predict deep venous thrombosis. Blood 104 (2004) 714a
19. Henke P.K., Varma M.R., Deatrick K.B., Drewyer N.A., Lynch E.M., Moore A.J., et al. Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost 95 (2006) 272-281
20. Wagner D.D. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 25 (2005) 1321-1324
21. Smeeth L., Cook C., Thomas S., Hall A.J., Hubbard R., and Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 367 (2006) 1075-1079
22. Lin J., Wakefield T.W., and Henke P.K. Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis 17 (2006) 265-270
23. Kikura M., Takada T., and Sato S. Preexisting morbidity as an independent risk factor for perioperative acute thromboembolism syndrome. Arch Surg 140 (2005) 1210-1217 discussion 1218
24. Prandoni P., Bilora F., Marchiori A., Bernardi E., Petrobelli F., Lensing A.W., et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 348 (2003) 1435-1441
25. Ray J.G., Mamdani M., Tsuyuki R.T., Anderson D.R., Yeo E.L., and Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 161 (2001) 1405-1410
26. Alikhan R., Cohen A.T., Combe S., Samama M.M., Desjardins L., Eldor A., et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14 (2003) 341-346
27. Samama M.M., Cohen A.T., Darmon J.Y., Desjardins L., Eldor A., Janbon C., et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 341 (1999) 793-800
28. Alikhan R., Peters F., Wilmott R., and Cohen A.T. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol 57 (2004) 1254-1257
29. Kniffin Jr. W.D., Baron J.A., Barrett J., Birkmeyer J.D., and Anderson Jr. F.A. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154 (1994) 861-866
30. Rutherford R.B. Prophylactic indications for vena cava filters: critical appraisal. Semin Vasc Surg 18 (2005) 158-165
31. Andtbacka R.H., Babiera G., Singletary S.E., Hunt K.K., Meric-Bernstam F., Feig B.W., et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 243 (2006) 96-101